SCHEMBL4916692

SCHEMBL4916692

CCOC(=O)c1c(NC(=O)OC(C)(C)CC(C)=O)c2cc(OCc3ccccc3)ccc2n1-c1ccc(OC(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
THRB P10828 2/20 0.41
MAPT P10636 5/20 0.39
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 4/20 0.39
GABRA1 P14867 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
RAD52 P43351 1/20 0.38
NMT1 P30419 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923444 0.89 MAPT (0.42) SMN1; SMN2THRBMAPTNPSR1MEN1
SCHEMBL4923150 0.88 SMN1; SMN2 (0.47) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4923393 0.87 SMN1; SMN2 (0.45) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4923342 0.85 ELANE (0.37) SMN1; SMN2THRBMAPTLMNATP53
SCHEMBL4922493 0.83 SMN1; SMN2 (0.43) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4922512 0.80 SMN1; SMN2 (0.49) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4922481 0.78 MEN1 (0.48) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4916704 0.78 SMN1; SMN2 (0.42) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4922068 0.76 SMN1; SMN2 (0.44) SMN1; SMN2THRBMAPTALDH1A1NPSR1
SCHEMBL4922071 0.76 SMN1; SMN2 (0.44) SMN1; SMN2THRBMAPTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, ARG1 SMN1; SMN2 3645/4885THRB 639/4885MAPT 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.